MONTREAL, June 27 /CNW Telbec/ - (TSX-V: BUG) Biophage Pharma Inc. (Biophage) is very pleased to announce that the PDS(R) Biosensor will make its commercial debut today at the Nanotoxicity 2007 Trade show in Paris, France. This product represents the first of many innovative biosensors in development by our Biosensor Division. Biophage President and CEO, Dr. Mandeville, will make a presentation on the PDS(R) technology platform and the targeted markets for this biosensor, which was designed for the rapid detection of toxicity (predictive toxicity) of metals and nanoparticles.
